X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
microbiology (98) 98
humans (95) 95
index medicus (80) 80
infectious diseases (60) 60
antifungal agents - pharmacology (59) 59
mycology (58) 58
pharmacology & pharmacy (46) 46
female (44) 44
microbial sensitivity tests (42) 42
male (38) 38
antifungal agents - therapeutic use (36) 36
susceptibility (36) 36
amphotericin-b (31) 31
antifungal agents (30) 30
middle aged (30) 30
adult (29) 29
epidemiology (25) 25
drug resistance, fungal (24) 24
life sciences (24) 24
voriconazole (23) 23
amphotericin b - pharmacology (22) 22
fungi (21) 21
bacterial infections and mycoses (20) 20
candida - drug effects (20) 20
infections (20) 20
fluconazole (19) 19
france (18) 18
itraconazole (18) 18
mucormycosis (18) 18
animals (17) 17
diagnosis (17) 17
posaconazole (17) 17
resistance (17) 17
aged (16) 16
filamentous fungi (16) 16
health aspects (16) 16
immunology (16) 16
adolescent (15) 15
amphotericin b - therapeutic use (15) 15
dermatology (15) 15
microbiology and parasitology (15) 15
zygomycosis (15) 15
amphotericin b (14) 14
aspergillosis (14) 14
caspofungin (14) 14
infection (14) 14
itraconazole - pharmacology (14) 14
aspergillus fumigatus - drug effects (13) 13
echinocandins (13) 13
echinocandins - pharmacology (13) 13
invasive aspergillosis (13) 13
mycoses (13) 13
risk factors (13) 13
aspergillosis - microbiology (12) 12
aspergillus fumigatus (12) 12
france - epidemiology (12) 12
therapy (12) 12
transplantation (12) 12
[ sdv.mp.myc ] life sciences [q-bio]/microbiology and parasitology/mycology (11) 11
[sdv.mp.myc]life sciences [q-bio]/microbiology and parasitology/mycology (11) 11
candida - isolation & purification (11) 11
candida-albicans (11) 11
dna, fungal - genetics (11) 11
in-vitro susceptibilities (11) 11
microbial sensitivity tests - methods (11) 11
mucormycosis - microbiology (11) 11
treatment outcome (11) 11
triazoles - pharmacology (11) 11
analysis (10) 10
aspergillus (10) 10
aspergillus - drug effects (10) 10
candida (10) 10
candidemia (10) 10
fungal-infections (10) 10
lipopeptides (10) 10
management (10) 10
mesh : humans (10) 10
polycyclic compounds (10) 10
young adult (10) 10
aged, 80 and over (9) 9
agents (9) 9
aspergillosis - drug therapy (9) 9
azole resistance (9) 9
azoles - pharmacology (9) 9
child (9) 9
fluconazole - pharmacology (9) 9
genotype (9) 9
identification (9) 9
in-vitro susceptibility (9) 9
mice (9) 9
molecular sequence data (9) 9
mycoses - microbiology (9) 9
surveillance (9) 9
triazoles - therapeutic use (9) 9
veterinary sciences (9) 9
albicans (8) 8
antifungal susceptibility (8) 8
azoles (8) 8
candidiasis - microbiology (8) 8
cystic fibrosis (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 04/2014, Volume 20, Issue 3, pp. 47 - 75
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 2009, Volume 15, Issue s5, pp. 66 - 70
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 1/2012, Volume 54, Issue suppl_1, pp. S35 - S43
Background. Mucormycosis is a deadly invasive fungal infection whose characteristics are only partially understood. Methods. Data on mucormycosis obtained in... 
Mucormycosis | Diabetes mellitus | Hematologic neoplasms | Mortality | Infections | Transplantation | Fungal infections | Diabetes | Epidemiology | Zygomycosis | INFECTIOUS DISEASES | INVASIVE ZYGOMYCOSIS | INFECTIONS | THERAPY | MICROBIOLOGY | TRANSPLANT RECIPIENTS | IMMUNOLOGY | EPIDEMIOLOGY | LIPOSOMAL AMPHOTERICIN-B | REGISTRY | Hematologic Neoplasms - microbiology | Wounds and Injuries - microbiology | Lung - microbiology | Dermatomycoses - drug therapy | Prognosis | Humans | Middle Aged | Male | Data Collection | Cerebellar Diseases - surgery | Antifungal Agents - therapeutic use | Young Adult | Cerebellar Diseases - complications | Cerebellar Diseases - pathology | Adult | Female | Cerebellar Diseases - microbiology | Retrospective Studies | Hematologic Neoplasms - complications | Mucormycosis - drug therapy | Child | Rhizopus - pathogenicity | Dermatomycoses - complications | France - epidemiology | Lung - pathology | Mucormycosis - epidemiology | Wounds and Injuries - surgery | Risk Factors | Proportional Hazards Models | Wounds and Injuries - complications | Treatment Outcome | Diabetes Mellitus - microbiology | Mucormycosis - complications | Mucormycosis - microbiology | Adolescent | Survival Analysis | Aged | Dermatomycoses - microbiology | Amphotericin B - therapeutic use | Fungi | Skin diseases | Regression analysis | Risk factors | Nonnative species | Hematologic Neoplasms | Rhizopus | Lung | Life Sciences | Antifungal Agents | France | Cerebellar Diseases | Mycology | Diabetes Mellitus | Dermatomycoses | Microbiology and Parasitology | Wounds and Injuries | Amphotericin B
Journal Article